New Salvo Against Opioid Abuse

• Autores: Rebecca Voelker
• Localización: JAMA: the journal of the American Medical Association, ISSN 0098-7484, Vol. 315, Nº. 17, 2016, pág. 1826
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Building on its recent efforts to reverse the US epidemic of opioid abuse, the FDA has issued draft guidance for the pharmaceutical industry to develop generic abuse-deterrent formulations of approved opioid medications.

    Last year, the FDA provided the industry with final guidance on developing abuse-deterrent versions of brand-name opioids. “We recognize that abuse-deterrent technology is still evolving and is only 1 piece of a much broader strategy to combat the problem of opioid abuse,” FDA Commissioner Robert Califf, MD, said in a statement (http://1.usa.gov/25nA0QN).